Oxalateassayprocedureno. 590 y = 1.06x -0.0006, r = 0.995,n = 30 bic acid (13, 14). In addition, interference from divalent cations and other substances is minimized or eliminated by the presence of EDTA in the Sample Diluent. The assay reaction is complete in <5 mm. The assay curve is linear up to 1 mmolJL. Oxalate recovery, using this new analytical procedure, was nearly 100% and the CV <3.0% for those oxalate concentrations tested. The results obtained by the present method and Sigma's oxalate procedure no. 590 agreed well.
Cross-reactivity with follitropin (2000mt. units/L) and thyrotropin (2 mt.units/L) was negligible; it was 0.016% with human choriogonadotropmn(1 x 106 mt. units/L). There was no interference by high concentrations of bilirubin (0.5 g/L), hemoglobin (7. 50 g/L), or triglycerides (13.5 g/L). Intra-, inter-, and total assay CVs were 3.75%, 7.1%, and 7.94%, respectively. 
Materials and Methods

Assay Format
The assay was performed as follows: we transferred (comprising microparticles, conjugate, and substrate) and carousel (containing the reaction cells) were placed in the IMx. The assay run was then initiated. During the assay, the IMx performed the following manipulations: Sample was added to microparticles to which an antibody to 13-LH was covalently bound. Unbound LH was separated from bound LH by transfer of the microparticles to a glass-fiber matrix followed by a buffer wash of the matrix. An antibody to a-LH to which alkaline phosphatase (EC 3.1.3.1) was conjugated was then added to the matrix and incubated with particles. Conjugate binding was terminated by washing the glass-fiber matrix with buffer. Substrate (4-methylumbelliferyl phosphate) was added to the matrix, and the rate of development of a fluorescent signal (resulting from conversion of the substrate to 4-methylumbelliferone) was quantified by the instrument. Analysis of up to 23 samples was completed within 40 mm.
Reagents
Monoclonal 13-LH antibody was selected to be carried on the microparticles. The antibody was purified by ion-exchange chromatography on CM-Sepharose (Pharmacia, Piscataway, NJ). Adsorbed antibody was step-eluted by increasing the concentration of sodium chloride in the column buffer (50 mmol/L sodium acetate, pH 5.0) from 150 to 250 mmol/L. Purified antibody was stored at -20 #{176}C until covalently coupled to carboxymethylated latex microparticles of uniform size (0.203 pm diameter; Seradyn, Indianapolis, IN).
Goat polyclonal antibody to a-thyrotropin, selected for conjugation to alkaline phosphatase, was affinity-purified with the use of Affigel 10 (Bio-Rad Labs, Richmond, CA), then stored at -20 #{176}C. First the antibody was adsorbed to Affigel in Ths buffer (10 nunollL, pH 7.5) containing 100 mmol of NaC1 per liter, then was eluted with citrate buffer (10 mmolJL, pH 2.5) containing 3.5 mol of MgC12 per liter. On subsequent days, concentrations were calculated by using the first-day calibration curve from the appropriate instrument. Assay precision was calculated by analysis of variance techniques (6).
Results and Discussion
A calibration curve demonstrating the relationship between LH (at 0,2, 10,25, 100, anSI 250 mt. unitsfL) and rate of development of fluorescence (counts/s2) is shown in Figure 1 . Maximum and background rates were 920 and 8 counts/s2, respectively.
The curve was calculated by using LH, mt.units per liter (Table 1) .
There was no cross-reactivity with follitropin (2000 mt.
unita/L) or thyrotropin (2 mt. units/L). Cross-reactivity with choriogonadotropin
(1 x 106 mt. units/L) was 0.016% (Table 2 ). There was no significant interference from triglycerides (13.5 gIL), hemoglobin (7.5 gIL), or bilirubin (0.5 gIL) (Table 3) . 96%. There was no significant difference in LH values determined with serum or heparmn-or EDTA-treated plasma samples. Recovery of LH added to heparin-and EDTA-plasma samples (n = 10) was 100.37 (±9.49%) (mean ± SD) and 104.73 (±7.56%), respectively, of that observed in the respective serum samples. Thus, either serum or plasma samples can be used for the assay. Assay of four patients' specimens, diluted serially into pooled human serum stripped of LH, showed excellent dilution parallelism (Figure 2) .
Clinical ranges of UI concentrations were determined in samples obtained from regularly menstruating women (fofficular, mid-cycle, and luteal phase), postmenopausal and amenorrheic women, prepubertal children, and men (Table 4) Assay precision is summarized in Table 5 . Within-and
between-assay
CVs were 3.75% and 7.10%, respectively. Intra-and interinstrument CVs were s3.75% and <4.4%, respectively.
In conclusion, we have developed an automated assay for lutropin that is sensitive, accurate, and precise. The IMx LH assay has the advantage of being nonisotopic, which reduces laboratory hazard and disposal costs resulting from the use of radiolabeled ligands. This assay should be useful for small to medium-size laboratories involved in the clinical diagnosis of reproductive pathology.
